Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Silver

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Cancer Treatment Reports|May 1, 1987
Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumorsV A Levin, M C Chamberlain, M D Prados, et al.
Journal of Neurosurgery|December 1, 1987
Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sourcesP H Gutin, S A Leibel, W M Wara, et al.
Molecular Cell|October 17, 1998
Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cellsJ Chen, D P Silver, D Walpita, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2P H Gutin, M D Prados, T L Phillips, et al.
NPJ Breast Cancer|June 2, 2021
Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancerRui Luo, Weelic Chong, Qiang Wei, et al.
Cancers|June 24, 2022
Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance MechanismMaysa Abu-Khalaf, Chun Wang, Zhenchao Zhang, et al.
Cancer Discovery|November 8, 2015
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in MalignancyManish Neupane, Allison P Clark, Serena Landini, et al.
Cell|March 14, 2007
Further evidence for BRCA1 communication with the inactive X chromosomeDaniel P Silver, Stoil D Dimitrov, Jean Feunteun, et al.
Cell|November 7, 2002
BRCA1 supports XIST RNA concentration on the inactive X chromosomeShridar Ganesan, Daniel P Silver, Roger A Greenberg, et al.
Cancer Discovery|May 12, 2012
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agentsNicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Cancer Treatment Reports|May 1, 1987
Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumorsV A Levin, M C Chamberlain, M D Prados, et al.
Journal of Neurosurgery|December 1, 1987
Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sourcesP H Gutin, S A Leibel, W M Wara, et al.
Molecular Cell|October 17, 1998
Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cellsJ Chen, D P Silver, D Walpita, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2P H Gutin, M D Prados, T L Phillips, et al.
NPJ Breast Cancer|June 2, 2021
Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancerRui Luo, Weelic Chong, Qiang Wei, et al.
Cancers|June 24, 2022
Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance MechanismMaysa Abu-Khalaf, Chun Wang, Zhenchao Zhang, et al.
Cancer Discovery|November 8, 2015
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in MalignancyManish Neupane, Allison P Clark, Serena Landini, et al.
Cell|March 14, 2007
Further evidence for BRCA1 communication with the inactive X chromosomeDaniel P Silver, Stoil D Dimitrov, Jean Feunteun, et al.
Cell|November 7, 2002
BRCA1 supports XIST RNA concentration on the inactive X chromosomeShridar Ganesan, Daniel P Silver, Roger A Greenberg, et al.
Cancer Discovery|May 12, 2012
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agentsNicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, et al.
Pageof 21